Lactobacillus gasseri SF1183 Affects Intestinal Epithelial Cell Survival and Growth by Blanda Di Luccia et al.
Lactobacillus gasseri SF1183 Affects Intestinal Epithelial
Cell Survival and Growth
Blanda Di Luccia1., Nicola Manzo1., Loredana Baccigalupi1, Viola Calabro`1, Elvira Crescenzi2, Ezio Ricca1,
Alessandra Pollice1*
1Department of Biology, University of Naples Federico II-MSA-Via Cinthia, Naples, Italy, 2 Istituto di Endocrinologia ed Oncologia Sperimentale-CNR-via S. Pansini, Naples,
Italy
Abstract
It is now commonly accepted that the intestinal microbiota plays a crucial role in the gut physiology and homeostasis, and
that both qualitative and quantitative alterations in the compositions of the gut flora exert profound effects on the host’s
intestinal cells. In spite of this, the details of the interaction between commensal bacteria and intestinal cells are still largely
unknown and only in few cases the molecular mechanisms have been elucidated. Here we analyze the effects of molecules
produced and secreted by Lactobacillus gasseri SF1183 on human intestinal HCT116 cells. L. gasseri is a well known species
of lactic acid bacteria, commonly associated to the human intestine and SF1183 is a human strain previously isolated from
an ileal biopsy of an healthy volunteer. SF1183 produces and secretes, in a growth phase-dependent way, molecule(s) able
to drastically interfere with HCT116 cell proliferation. Although several attempts to purify and identify the bioactive
molecule(s) have been so far unsuccessful, a partial characterization has indicated that it is smaller than 3 kDa, thermostable
and of proteinaceous nature. L. gasseri molecule(s) stimulate a G1-phase arrest of the cell cycle by up-regulation of
p21WAF1 rendering cells protected from intrinsic and extrinsic apoptosis. A L. gasseri-mediated reduction of apoptosis and
of cell proliferation could be relevant in protecting epithelial barrier integrity and helping in reconstituting tissutal
homeostasis.
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Introduction
Several recent studies have shown that commensal bacteria,
forming the human gut microbiota, establish complex symbiotic
interactions with cells of the GastroIntestinal Tract (GIT) and that
these interactions significantly contribute to human health
[1,2,3,4]. Metagenomic experiments have indicated that the vast
majority of the intestinal bacteria belong to two phyla, the Gram-
negative Bacteroidetes and the Gram-positive Firmicutes, includ-
ing the large class of Clostridia and the lactic acid bacteria [5,6].
However, the composition of the gut microbiota is known to
change transiently as a consequence of a variety of factors such as
age, diet, enteral infections, pharmacological treatments and
immunosuppression [7,8,9]. Changes in the microbiota composi-
tion have also been associated to several diseases, such as chronic
inflammation of the GIT, diabetes and obesity [7,10,11,12,13,14],
and the oral administration of members of the microbiota has
been considered as a potential clinical tool to relieve intestinal
dysfunctions [15,16,17,18,19,20]. Interest in the beneficial func-
tions of the human microbiota has resulted in the selection of
specific strains with putative health-promoting capacities that are
recognized as probiotics and are generally selected from isolates of
the Lactobacillus or Bifidobacterium species. Probiotic bacteria have
been shown capable to modulate systemic inflammation, cell
proliferation and apoptosis, and such properties proposed as useful
for future immunomodulatory and cancer prevention strategies
[13,14,21,22]. In vitro studies have reported the anti-proliferative
and pro-apoptotic effects of Lactobacillus and Bifidobacterium spp. in
various cancer cell lines [23,24,25,26], while in vivo studies have
shown the inhibitory activity of probiotics on liver, bladder and
colon tumours in animal models [27,28,29,30].
The molecular mechanisms of interaction between intestinal
cells and bacteria have been studied in detail only in few cases and
often quorum-sensing autoinducers, communication molecules
released by bacteria at high densities, have been shown to
modulate host responses either directly or through regulation of
bacterial genes involved in gut colonization and host signaling
[31,32]. An example in this context is the quorum-sensing
pentapeptide CSF (Competence and Sporulation Factor) of
Bacillus subtilis that is taken up by Caco-2 cells via the membrane
transporter OCTN2 (organic cation transporter 2) and that
contributes to eukaryotic cell homeostasis activating survival
pathways (p38 MitogenActivatedProteinKinase (MAPK) and
protein kinase B) [33]. In other cases the secreted bacterial
effectors have not been identified: still unidentified molecules
secreted by Lactobacillus rhamnosus GG were shown to prevent
cytokine-induced apoptosis on two different intestinal cell model
systems (YAMC-young adult mouse colon; HT29-colon carcino-
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ma) [34]; molecules secreted by L. reuteri were shown to potentiate
tumour necrosis factor (TNFa)-induced apoptosis in myeloid
leukemia derived cells. In the latter example L. reuteri molecules
were found to: i) suppress NF-kB activation by inhibiting IkBa
degradation; ii) downregulate nuclear factor-kB (NF-kB)-depen-
dent gene products affecting cell proliferation and survival; iii)
promote apoptosis by enhancing mitogen-activated protein kinase
(MAPK) activities including c-Jun N-terminal kinase and p38
MAPK [35].
Lactobacillus gasseri is a well characterized species of low GC
gram-positive bacteria, known to represent one of the major
homofermentative Lactobacillus of the human intestine [36]. We
have isolated the SF1183 strain of L. gasseri from an ileal biopsy of
a human healthy volunteer and, in particular, from the fraction of
bacteria tightly associated to the epithelial cells. SF1183 was
shown to have antimicrobial activity against a panel of entero-
pathogens and to form a matrix (biofilm) in standard laboratory as
well as in simulated intestinal conditions [36].
This study investigates the effects of molecules produced and
secreted by L. gasseri SF1183 on colorectal HCT116 cells, both at
the molecular and cellular level. Since HCT116 cells are
responsive to TNFa-induced apoptosis [37,38], we tested their
response to the presence of L. gasseri SF1183 supernatant.
Moreover, we extended our analysis to the effects of another
inducer of apoptosis to evaluate the specificity of the observed
effect.
Results and Discussion
The Conditioned Medium (CM) of L. gasseri SF1183
Protects HCT116 cells from TNFa Induced Apoptosis
Among the most common features of chronic intestinal
inflammations, such as Crohn and irritable bowel diseases (IBDs),
is the increase in the production of inflammatory cytokines,
epithelial cell apoptosis and immune cell infiltration, leading to
disruption of the intestinal epithelial integrity. TNFa is among the
cytokines more largely produced under these conditions. It is
known to regulate both anti- and pro-apoptotic signaling pathways
and determine the cell fate by controlling the balance between the
two pathways [39]. To study the effects of molecules secreted by L.
gasseri on TNFa-induced apoptosis we used the TNFa sensitive
HCT116 human colon cancer cells as a model of intestinal
epithelial cells [37]. As a marker of apoptosis we followed the
proteolytic cleavage of PARP-1, a regulator of the DNA base
excision repair pathway essential for the maintenance of genomic
integrity and for survival in response to genotoxic insults [40].
PARP-1 is known to be specifically proteolysed by the Caspase 3
to a 24 kDa DNA-binding domain (DBD) and a 89 kDa catalytic
fragment during the execution of the apoptotic program [41]. To
set up the experimental conditions, HCT116 cells were incubated
with 1 nM TNFa for various times and cell extracts analyzed by
western blotting with anti-PARP-1 antibody. As shown in
Figure 1A, the amount of proteolyzed PARP-1 increased with
the time of exposure to TNFa. Therefore we decided to use
8 hours of treatment with 1 nM TNFa to detect either induction
or inhibition of PARP cleavage, for all therein experiments
involving a TNF-a activation.
A filter-sterilized conditioned medium (CM) of a L. gasseri
SF1183 culture was added (20% v/v) to HCT116 cells and
incubated for 16 hours. Then, TNFa was added and, after
additional 8 hours of incubation, cells were harvested and whole
extracts analyzed by western blotting with anti-PARP-1 antibody.
As shown in Figure 1B the bacterial CM alone did not have any
effect on PARP-1 cleavage while was able to significantly reduce
the TNFa-induced proteolytic activation of PARP-1.
L. gasseri is a homofermentative bacterium that, therefore, grows
producing lactic acid as the only metabolic end-point of
carbohydrate metabolism. As a consequence, its growth medium
is acidified during growth to reach a final pH value of 4.0. To
verify that the reduction in the extent of PARP-1 cleavage was due
to secreted molecules and not to the acidification of the growth
medium, the same experiment of Figure 1B was performed adding
to HCT116 cells the same amount (20% v/v) of the fresh bacterial
growth medium (MDM) either at its normal pH (pH 7.0) or
acidified to pH 4.0 with lactic acid. As shown in Fig. 1C, both
media did not have any effect on TNFa-induced cleavage of
PARP-1 suggesting that the CM of L. gasseri SF1183 contains
molecules with anti-apoptotic activity.
The CM of L. gasseri SF1183 Contains Bioactive Soluble
Molecule(s) Secreted During the Stationary Phase of
Growth
As a first step toward the characterization of molecule(s)
involved in the observed effect, we decided to size-separate the
CM of L. gasseri by using a 3 kDa molecular mass cut-off filter. As
Figure 2A clearly shows we observed bioactivity largely in the
filtrate, indicating a small (less than 3 kDa) molecular mass for the
effector(s) molecule(s). Further, different enzymatic treatments of
the CM indicated that bioactivity is proteinase-K sensitive,
suggesting a proteinaceous nature (Figure 2B). After a heat
treatment of 30 minutes at 100uC the CM was still able to reduce
the TNFa-induced cleavage of PARP-1 at the same extent of
untreated CM (Figure 2C), suggesting that the bioactive
molecule(s) is not thermolabile. Often bacteria secrete bioactive
molecules during their stationary phase of growth. We thus tested
the CM of L. gasseri cultures at different stages of growth and
observed bioactivity produced only in early and late stationary
phase of growth (24 and 48 hours of growth, respectively)
(Figure 2D). All experiments therein reported have been
performed by using the size-fractionated (,3 kDa) CM of a late
stationary culture of L. gasseri SF1183.
The CM of L. gasseri SF1183 Affects Cell Proliferation of
HCT116 Cells
To characterize the cellular response to L. gasseri secreted
molecules, we analyzed HCT116 cell number and viability after
growth in presence of CM. Briefly, cells were incubated for 24
hours with CM of L. gasseri (20% vol/vol) and then analyzed both
for the number of cells by counting in a Burker chamber and for
cell viability by MTS assay. As Figure 3A shows, the CM caused a
30% reduction in the number of cells. The MTS assay (Figure 3B)
showed a reduction in cell viability of the same order of
magnitude.
To get more insights into the cellular response, we looked at the
cell-cycle distribution profile and at the expression of cell cycle-
related molecular markers in HCT116 cells exposed to TNFa
and/or to the CM of L. gasseri.
The cell cycle distribution was analyzed by flow cytometry and
showed that treatment with TNFa causes a drastic increase in the
subG1 cell population (from 4 to 28%) while the pre-treatment of
cells with the CM of L. gasseri strongly reduced the TNFa induced
effect (Figure 4A), thus supporting our previous data indicating a
reduction in the extent of PARP-1 cleavage (see Figure 1B,
2B, 2C). Importantly, we found that the CM alone caused a
significant increase (up to 18%) in the G1 population of cells with a
compensatory decrease in S/G2 cells, indicating that cells were
Effects of Probiotic L.gasser on Intestinal Cells
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unable to resume the cell cycle at normal phase transit rate
(Figure 4A), consistently with previous MTS and proliferation
data. This suggests that, indeed, molecules secreted from L. gasseri
can drastically interfere with proliferation of HCT116 cells,
rendering them less prone to TNFa induced apoptosis.
Expression of the cell cycle markers p21WAF1 and pERKs was
also investigated to explore the effects of the CM of L. gasseri at the
molecular level. p21WAF1 (also known as cyclin-dependent kinase
inhibitor 1) is a regulator of cell cycle progression at the S phase
that acts as an inhibitor of cyclin-dependent kinase, and occupies a
central position in the regulation of the cell cycle in many tissues
[42,43]. Levels of p21WAF1 protein are regulated during the cell
cycle at the levels of transcription and protein degradation,
although many questions remain on the mechanism of p21
proteolysis [44,45]. Extracellular signal-regulated kinases
(ERK1,2) are members of the MAPK super family that can
mediate cell proliferation and apoptosis. Activated (phosphorylat-
ed) ERKs, are usually associated with active cell proliferation [46],
while p21 increase correlates with a G1 cell cycle arrest [47].
Immunoblots with the appropriate antibodies showed that
treatment with CM significantly induced p21WAF independently
from TNFa (Figure 4B; compare lanes 1–2 with 3–4) while pERKs
expression was inhibited in CM treated cells, strongly supporting
the antiproliferative effect of molecule(s) present in L. gasseri
supernatant.
Altogether these experiments clearly indicate that L. gasseri
supernatant exerts a cytostatic but not a cytotoxic effect on
epithelial colon cells.
The CM of L. gasseri SF1183 Protects HCT116 Cells from
Cisplatin Induced Apoptosis
To test whether bioactive molecules present in L. gasseri
supernatant could exert anti-apoptotic effects against other
apoptosis-inducers we preincubated HCT116 cells with CM and
then treated them with 30 mM cisplatin to induce the intrinsic
apoptotic pathway. As shown in Figure 5A cytofluorimetric
analysis indicate that a G1 cell cycle arrest is induced by CM
addition which causes cells to be more resistant to cisplatin
induced apoptosis. These observations are supported, at the
molecular level, with an increase in p21WAF1 levels and a
decrease of ERKs activation when CM was added to the cells
(Figure 5B, lanes 1,2). Consistently, pretreatment of cells with CM
determined a reduction in the extent of PARP-1 cleavage when
cells were subjected to cisplatin action (Figure 5B, lanes 3,4).
Altogether our results clearly indicate that probiotic L. gasseri
protects intestinal epithelial cells from apoptosis induced by
Figure 1. HCT116 cell response to L. gasseri CM with or without TNFa treatment. Western blot with anti-PARP-1 antibody of whole cell
extracts from HCT116 cells incubated in (A) complete cell culture medium supplemented or not with TNFa (1 nM) for 2, 8 or 24 hours; (B) complete
cell culture medium supplemented or not with CM (20%v/v) for 16 hours before treatment with 1 nM TNFa for 8 hours; (C) complete cell culture
medium supplemented or not with TNFa (1 nM) for 8 hours and MDM (20%v/v) or MDM+lactic acid pH4 (20%v/v). After the treatments cells were
collected, lysed and protein concentration determined. Equal amount of cell lysates were fractionated on SDS-PAGE and analyzed by western blotting
with antibodies against PARP-1. Actin was used as a loading control.
doi:10.1371/journal.pone.0069102.g001
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Figure 2. L. gasseri secretes thermostable, bioactive molecule(s) of proteinaceous nature during the stationary phase of growth.
HCT116 cells were incubated in complete cell culture medium supplemented or not with TNFa (1 nM) for 8 hours and with A) CM fractionated with a
cut-off of 3 kDa, or B) CM treated with different enzymes [Trypsin, Proteinase K, DNAse I, RNAse A], or C) CM treated at 100uC for 30 minutes, or D) CM
of cultures at the indicated phases of growth. After the treatments, cells were collected, lysed and total cell extracts were analyzed by western
blotting with antibodies against PARP-1. Actin was used as a loading control. PARP-1 band intensity was evaluated by ImageQuant analysis on at least
two different expositions to assure the linearity of each acquisition. Values expressed as ratio with the corresponding actin values and normalised to
the reference point (PARP-1 cleavage in medium). Percentage of increase (+) or decrease (–) with respect to the intensity of the reference point are
indicated.
doi:10.1371/journal.pone.0069102.g002
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inflammatory cytokines or cytotoxic drugs, causing cell cycle
arrest.
Conclusions
The main result of this report is that the conditioned medium of
a stationary culture of the human isolate SF1183 of L. gasseri
contains molecule(s) able to affect cell proliferation of HCT116
cells, protecting them from intrinsic as well as extrinsic, TNFa-
induced, apoptosis. Chronic inflammations cause an increase in
inflammatory cytokines (such as TNFa), epithelial cell apoptosis
and immune cell infiltration, leading to disruption of the intestinal
epithelial integrity. Therefore, a reduction of cell proliferation
could protect epithelial barrier integrity and help in reconstituting
tissutal homeostasis.
The L. gasseri molecule(s) responsible of the observed effects is
proteinaceous, has a small (less than 3 kDa) size and its synthesis is
growth phase-dependent, occuring only in bacterial cells in
stationary phase. Those properties are suggestive of bacterial
quorum-sensing autoinducers, communication molecules pro-
duced at high cell density and known to act as modulator of
bacterial host responses [31,32,33]. Unfortunately, the definition
of the chemical nature of the molecule(s) secreted by L. gasseri
SF1183 and able to affect HCT116 cells has been so far
unsuccessful. The size-fractionated (less than 3 kDa) CM of L.
gasseri was analyzed by gel filtration chromatography with a
Superdex Peptide 10/300 GL (GE Healthcare Life Sciences)
column and two main peaks were obtained (Fig. S1 in File S1).
Chromatographic fractions containing either one of the two peaks
were tested for the ability to reduce the TNFa-induced cleavage of
PARP-1 (Fig. S2A in File S1). Only one of the fractions (Fraction
1) was shown to reduce the TNFa-induced cleavage of PARP-1 at
the same extent of the unfractionated CM (Fig. S2B in File S1).
Unfortunately, attempts to analyze Fraction 1 by mass-spectrom-
etry have been so far unsuccessful, probably because of the
minimal concentration of molecules in the fraction. To define the
chemical nature of the molecule(s) affecting HCT116 cells and
identify its cellular and molecular targets will then be a future and
challenging task.
Materials and Methods
Bacterial Growth and Preparation of Conditioned
Medium
Lactobacillus gasseri (SF1183) was grown in MRS broth (Difco,
Detroit, MI) for 24 hours at 37uC and the culture diluted and used
to inoculate MDM (Glucose 10 g/L, Sodium acetate 5 g/L,
KH2PO4 3 g/L, K2HPO4 3 g/L, MgSO4 *7H2O 0.2 g/L, L-
Alanine 100 mg/L, L-Arginine 100 mg/L, L-Aspartic acid
200 mg/L, L-Cysteine 200 mg/L, L-Glutamic 200 mg/L, L-
Histidine 100 mg/L, L-Isoleucine 100 mg/L, L-Leucine 100 mg/
L, L-Lysine 100 mg/L, L-Methionine 100 mg/L, L-Phenylala-
nine 100 mg/L, L-Serine 100 mg/L, L-Tryptophan 100 mg/L,
L-Tyrosine 100 mg/L, L-Valine 100 mg/L, Nicotinic acid 1 mg/
L, Pantothenic acid 1 mg/L, Pyridoxal 2 mg/L, Riboflavin 1 mg/
L, Cyanocobalamin 1 mg/L, Adenine 10 mg/L, Guanine 10 mg/
L, Uracil 10 mg/L) minimal medium. Cells of SF1183 were then
grown anaerobically for 48 hours at 37uC. The culture was
centrifuged (1000 g for 10 min at RT) and the supernatant
(conditioned medium, CM) was filtered-sterilized through a
0.22 mm low-protein binding filter (Millipore, Bedford, MA,
US). CM treated with proteases and nucleases was prepared as
described above and size fractionated (3-kDa cutoff spin column;
Centricon, Millipore). Before treatment with trypsin (GIBCO) or
proteinase K (Invitrogen), or DNasi I, or RNasi A (Invitrogen, Life
Technology, Monza, Italy) at a final 100 mg/ml concentration for
60 min at 37uC the pH of CM was neutralized with concentrated
NaOH (10 N). After the enzymatic treatments CM was acidified to
pH 4.0 using concentrated HCl and fractionated as described
above to remove the enzymes.
Cell Culture and Treatment with Bacterial CM
HCT116 cells (ATCC CCL 247) derived from a poorly-
differentiated colonic adenocarcinoma and were maintained in
RPMI 1640 supplemented with 10% fetal bovine serum and 1%
penicillin-streptomycin. Cells were cultured at 37uC in humidified
atmosphere of 5% CO2. The bacterial CM was employed for the
treatment at 20% v/v concentration in complete growth medium.
After incubation of 16 hours with CM (20% v/v), TNFa (1 nM)
(Millipore, Milan, Italy) or Cisplatin (30 mM) (Sigma Milan, Italy)
was added and cells harvested after 8 hours or 24 hours of
treatment. Cells were lysed and cell extracts prepared for Western
blot and FACS analysis, respectively, as described below.
Figure 3. The CM of L. gasseri SF1183 affects HCT116 cell
number but not cell viability. Proliferating HCT116 cells were
incubated in complete cell culture medium supplemented or not with
CM (20%v/v). After 24 hours (A) controls (NT) and CM-treated (CM) cells
were collected and counted in a Burker chamber; or (B) incubated with
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophe-
nyl)-2H-tetrazolium as a substrate and the absorbance of converted
formazan measured at 490 nm.
doi:10.1371/journal.pone.0069102.g003
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SDS-PAGE and Western Immunoblot Analysis
Cells were harvested in lysis buffer (50 mM Tris-HCl pH 7.5,
5 mM EDTA, 150 mM NaCl, 1% NP-40, 1 mM phenylmethyl-
sulfonyl fluoride, 0.5% sodium deoxycholate, and protease
inhibitors) and total protein extract prepared as previously
described [48]. Briefly, cell lysates were incubated on ice for 40
minutes, and the extracts were centrifuged at 15000 g for 15
minutes to remove cell debris. Protein concentration was
determined by the Bio-Rad protein assay (Bio-Rad). After the
addition of 2x Laemmli buffer (SIGMA), samples were boiled at
100uC for 5 minutes and resolved by SDS-polyacrylamide gel
electrophoresis (10% or 12%). Proteins were transferred to
polyvinylidenedifluoride (PVDF) membranes (Millipore Milan,
Italy) as previously described [49]. The membranes were blocked
in 5% w/v milk buffer (5% w/v non-fat dried milk, 50 mM Tris,
200 mM NaCl, 0,2% Tween 20) and incubated with primary
antibody diluted in 5% w/v milk or bovine serum albumine buffer
for 2 hours at room temperature or overnight at 4uC. Primary
antibodies were anti-rabbit PARP-1 (Cell Signaling, EuroClone,
Milan, Italy), anti-rabbit pErks 42/44 (Cell Signaling, EuroClone,
Milan, Italy), anti-rabbit p21WAF1 (Santa-Cruz Biotechnology,
DBA Milan-Italy), anti-goat b-actin (Santa-Cruz Biotechnology
DBA Milan, Italy). Data were visualized by enhanced chemilu-
minescence method (ECL, GE-Healthcare Milan, Italy) using
HRP-conjugated secondary antibody (Santa-Cruz Biotechnology
DBA Milan, Italy) incubated 1 hour at room temperature, and
analysed by Quantity One Hsoftware of ChemiDoc TMXRS
system (Bio-Rad Milan, Italy).
Cell Growth and Flow Cytometry Analysis
HCT116 cells were plated in 35 mm dishes at the cell density of
2,56105 cells/plate. For cell growth analysis, cells were cultured in
complete growth medium supplemented or not with bacterial CM
at 20% v/v concentration for 24 hours. After the treatment, cells
were collected and counted in a Burker chamber. Flow cytometry
analysis was performed as previously described [50]. Briefly, cells
were washed twice with PBS and harvested at 1500 g with 0.05%
trypsin in 0.15% Na2EDTA. Cells were then centrifuged, washed
in PBS, fixed with ice-cold 70% ethanol, and stored overnight at
4uC. Fixed cells were washed in PBS and then incubated with
propidium iodide (50 mg/ml) and RNAse A (10 mg/ml) for 30 min
at room temperature. Data acquisition was performed using a
CyAn ADP Flow Cytometer (Beckman Coulter, Inc., Milano,
Italy) and Summit Software.
MTS Assay
HCT116 cells were cultured at a density of 2,56105 cells per
well in flat bottomed 6-well plates and supplemented or not with
Figure 4. The CM of L. gasseri SF1183 affects cell proliferation of HCT116 cells. Proliferating HCT116 cells were incubated in complete cell
culture medium supplemented or not with CM (20%v/v) and/or TNFa (1 nM). After the treatments, cells were collected and treated for flow-
cytometric analysis (A and Fig. S3 in File S1) or western blot (B) with the indicated antibodies.
doi:10.1371/journal.pone.0069102.g004
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CM (20% v/v) for 24 hours. After treatment, CellTiter 96H
AQUEOUS One Solution Reagent (Promega, Madison, WI, US)
was added to each well according to the manufacturer’s
instructions. After 30 minutes cell viability was determined by
measuring the absorbance at 490 nm using a Multiscan spectrum
(Thermo Electron Corporation).
Supporting Information
File S1 Supplemental figures. Figure S1, the CM of L. gasseri
was size fractionated with a 3 kDa molecular mass cut-off filter and
loaded on a gel filtration chromatographic column (Superdex
Peptide 10/300 GL, GE Healthecare Life Sciences). The elution
buffer was AMAC 0.3 M. Two main peaks were observed at
220 nm. Figure S2, chromatographic fractions from the experi-
ment of Fig. S1 were tested by western blotting with anti-PARP-1
antibody (A). As a control, cells were also treated with the elution
buffer (AMAC 0,3 M). (B) Densitometric analysis of the western
blot. PARP-1 band intensity was evaluated by ImageQuant
analysis on at least two different expositions to assure the linearity
of each acquisition. Values are expressed as ratio with the
corresponding actin values and normalised to the reference point
(PARP-1 cleavage in medium). Percentage of increase (+) or
decrease (–) with respect to the intensity of the reference point are
indicated. Figure S3, enlargment of part of Fig. 4 showing the
output of the FACS analysis. Figure S4, enlargment of part of
Fig. 5 showing the output of the FACS analysis.
(PDF)
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